The analysis predicted that GLP-1 drugs could prevent thousands of cases of diabetes and cardiovascular disease and add months of high-quality life to patient lifetimes on average
Since it helps the body to produce as much insulin as the body needs, it helps the body regulate how the sugar is processed
These programs can reduce brand-name costs to $0 to $500/month, though eligibility restrictions apply and coverage can change with little notice
It belongs to a novel class of drugs known as triple agonists, meaning it simultaneously activates three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Genetics: Variations in hormone receptor sensitivity and metabolic rate may affect response to triple agonist therapy, though evidence on genetic predictors is currently limited and emerging
This reflects how the body can adapt to lower weight and regulated appetite